TY - JOUR A1 - Winkelmann, Anne Ria A1 - Schneider, Markus A1 - Hartmann, Sylvia A1 - Schnitzbauer, Andreas A1 - Zeuzem, Stefan A1 - Peveling-Oberhag, Jan Franz-Josef A1 - Hansmann, Martin-Leo A1 - Walter, Dirk Henning T1 - Microsatellite instability occurs rarely in patients with Cholangiocarcinoma : a retrospective study from a German tertiary care hospital T2 - International journal of molecular sciences N2 - Immune-modulating therapy is a promising therapy for patients with cholangiocarcinoma (CCA). Microsatellite instability (MSI) might be a favorable predictor for treatment response, but comprehensive data on the prevalence of MSI in CCA are missing. The aim of the current study was to determine the prevalence of MSI in a German tertiary care hospital. Formalin-fixed paraffin-embedded tissue samples, obtained in the study period from 2007 to 2015 from patients with CCA undergoing surgical resection with curative intention at Johann Wolfgang Goethe University hospital, were examined. All samples were investigated immunohistochemically for the presence of MSI (expression of MLH1, PMS2, MSH2, and MSH6) as well as by pentaplex polymerase chain reaction for five quasimonomorphic mononucleotide repeats (BAT-25, BAT-26, NR-21, NR-22, and NR-24). In total, 102 patients were included, presenting intrahepatic (n = 35, 34.3%), perihilar (n = 42, 41.2%), and distal CCA (n = 25, 24.5%). In the immunohistochemical analysis, no loss of expression of DNA repair enzymes was observed. In the PCR-based analysis, one out of 102 patients was found to be MSI-high and one out of 102 was found to be MSI-low. Thus, MSI seems to appear rarely in CCA in Germany. This should be considered when planning immune-modulating therapy trials for patients with CCA. KW - microsatellite instability KW - cholangiocarcinoma KW - immunohistochemistry KW - PCR Y1 - 2018 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/46332 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-463324 SN - 1422-0067 SN - 1661-6596 N1 - This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0). VL - 19 IS - 5, Art. 1421 SP - 1 EP - 10 PB - Molecular Diversity Preservation International CY - Basel ER -